期刊文献+

4-(2,4-二氟苯甲酰基)-哌啶的合成研究

The Synthesis of 4-(2,4-Difluorobenzoyl)-Piperidine
下载PDF
导出
摘要 利培酮作为临床上用于治疗精神分裂症最常用的药物之一,其原料药的合成技术研究具有十分广阔的前景。本文提供了一种利培酮的中间体——4-(2,4-二氟苯甲酰基)-哌啶的制备方法,以4-哌啶甲醛和2,4-二氟苯肼为原料,二甲基亚砜为溶剂,氯化铜(CuCl2)为催化剂,过氧化叔丁醇(TBHP)为氧化剂,经自由基偶联反应制备4-(2,4-二氟苯甲酰基)-哌啶,并通过核磁等表征确认结构。该方法实验步骤简单,反应条件温和,合成成本低,收率高(83.1%),为该化合物的合成提供了一种新思路。 Risperidone is one of the most commonly used drugs for the treatment of schizophrenia in clinic.The research on the synthesis technology of risperidone API has a very broad prospect.This paper provides a preparation method of 4-(2,4-difluorobenzoyl)-piperidine,an intermediate of risperidone.4-(2,4-difluorobenzoyl)-piperidine was prepared by free radical coupling reaction with 4-piperidine formaldehyde and 2,4-difluorophenylhydrazine as raw materials,DMSO as solvent,CuCl2as catalyst and TBHP as oxidant,and the structure was confirmed by NMR and other characterization.The method has the advantages of simple experimental steps,mild reaction conditions,low synthesis cost and high yield(83.1%),which provides a new idea for the synthesis of the compound.
作者 蒙利民 范钢 王文斌 罗玉全 徐作武 何剑锋 徐慧婷 Meng Limin;Fan Gang;Wang Wenbin;Luo Yuquan;Xu Zuowu;He Jianfeng;Xu Huiting(Zhejiang Medicine Co.,Ltd.,Shaoxing 312000,China;Zhejiang Engineering Research Center of Fat-soluble Vitamin,Shaoxing University,Shaoxing 312000,China;College of Chemistry and Chemical Engineering,Shaoxing University,Shaoxing 312000,China)
出处 《山东化工》 CAS 2022年第23期19-21,共3页 Shandong Chemical Industry
关键词 利培酮 4-(2 4-二氟苯甲酰基)-哌啶 合成 精神分裂症 risperidone 4-(2,4-difluorobenzoyl)-piperidine synthesis schizophrenia
  • 相关文献

参考文献16

二级参考文献158

  • 1郑鸿伟,王灵君,刘光伟,张亚莉,邓巧恩,乔德峰,刘惠敏.氨磺必利对精分患者的治疗效果及对PRL、糖代谢水平的影响[J].湖南师范大学学报(医学版),2020,17(2):163-166. 被引量:14
  • 2张继志.新型抗精神病药利培酮[J].国外医学(精神病学分册),1995,22(3):137-139. 被引量:39
  • 3陈晋东,赵靖平,李乐华,国效峰,吴仁容,翟金国,王传跃,谢世平,高成阁,丁瑛,陈远光.阿立哌唑治疗精神分裂症的多中心随机双盲对照试验[J].中国新药与临床杂志,2005,24(11):845-848. 被引量:65
  • 4US FDA.FDA Approves New Drug for Schizophrenia[EB/OL].[2006-12-20].http://www.fda.gov/News-Events/ Newsroom/PressAnnouncernents/2006/ucm108812.htm.
  • 5Kankan RN,Rao DR,Pathi SL.Process for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes:WO,2009047499[P].2009-04-16.(CA 2009,150:423221).
  • 6Barti J,Benovsky E Krajcovic J.Synthesis of paliperidone:WO,2009074333[P].2009-06-18.(CA2009,151:56864).
  • 7Dolitzky BZ,Shapiro E,Ini S,et al.Process for the synthesis of CMHTP and intermediates thereof:US,20080214809[P].2008-09-04.(CA 2008,149:307878).
  • 8Bristol JA,Gross I,Lovey RG.An improved synthesis of 2-amino-3-alkyloxypyridines by a phase-transfer catalyzed ether synthesis[J].Synthesis,1981,(12):971-973.
  • 9Dehmlow EV.Advances in phase-transfer catalysis[J].Angew Chem Int EdEngl,1977,16 (8):493-505.
  • 10Ravi JRR,Pulla Reddy M,Adibhatla Kali Satya BR,et al.An improved,industrially viable process for the preparation of high purity paliperidone:WO,2009010988[P].2009-01-22.(CA2009,150:168378).

共引文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部